|COVID–19 NEWS||Jempol District Health Centre, RISDA set up mobile vaccination team | COVID-19 deaths start to rise again in Brazil | COVID: Five more new clusters in Sarawak | COVID: Watching TV raises vaccination awareness for disabled teen | Japan to provide AstraZeneca vaccines to Malaysia if circumstances allow ||
MOSCOW, May 10 -- South Korean pharmaceutical company Celltrion launched the global supply of its COVID-19 antibody treatment, according to Celltrion Healthcare, an affiliate managing overseas deals.
The company signed a contract with Pakistan to export around 100,000 pills of Rekirona, enough for 30,000 people.
"Talks are also currently underway to export Rekirona to other countries in Europe and South America, as well as India," Sputnik reported a company official as quoted by Yonhap News Agency.
Rekirona is a monoclonal antibody drug, designed to battle COVID-19. It has been administered to COVID-19 patients in South Korea who are at higher risk to contracting the disease.
The company has also said that they have completed a phase three clinical trial in over 10 countries to make sure the safety and efficacy of the treatment is valid.
Bernama is the trusted source of reliable real-time comprehensive and accurate news for both the public and media practitioners. Our news is published at www.bernama.com ; BERNAMA TV on: Astro Channel 502, unifi TV Channel 631, MYTV Channel 121 IFLIX; and Bernama Radio broadcasting locally on FM93.9 in Klang Valley, Johor (FM107.5), Kota Kinabalu (FM107.9) and Kuching (FM100.9).
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamatadio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial